Neo Ivy Capital Management

Position in BSX — Boston Scientific Corp

CIK 1727783 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$893,309

+$99,335 QoQ

Shares Held

14,236

+92.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $4,686,677 across 2 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)	Open
1	GEHC	GE HealthCare Technologies Inc.	47,310	$3,028,313
2	ABT	Abbott Laboratories	18,276	$1,658,364

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$893,309	14,236	+92.6%	Shares	Sole	2026-05-15
2025-06-30	$793,974	7,392	+195.9%	Shares	Sole	2025-08-12
2022-03-31	$110,636	2,498	+27.0%	Shares	Sole	2022-05-16
2021-12-31	$83,558	1,967	-85.5%	Shares	Sole	2022-02-15
2021-09-30	$587,543	13,541	+3.7%	Shares	Sole	2021-11-16
2021-06-30	$558,231	13,055	+175.8%	Shares	Sole	2021-08-16
2021-03-31	$182,969	4,734	-72.3%	Shares	Sole	2021-10-07
2020-09-30	$652,817	17,085	+26.2%	Shares	Sole	2020-11-17
2020-06-30	$475,424	13,541	+148.0%	Shares	Sole	2020-08-17
2020-03-31	$178,159	5,460	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.